Pfizer/BioNTech mRNA Combo Influenza and COVID Shot Efficacy Fails in Trial
Pfizer and BioNTech recently announced that a new mRNA vaccine designed to protect against both COVID-19 and influenza in a single shot faced a major setback after failing to achieve one of its primary goals in a late-stage trial. The “primary goal” missed in the late-stage trials was the ability to effectively prevent influenza B. […]
CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]
Febrile Seizures Identified as Potential Cause of Sudden Unexplained Deaths of Children
A study published in the Feb. 13, 2024 journal Neurology designed to investigate the cause of sudden unexplained death of children, which usually occurs during sleep, found that the deaths of seven toddlers examined in the study were related to convulsions, also known as seizures. This finding suggests that many unexplained sleep-related deaths unexpectedly occurring […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Congress Orders Research to Assess COVID Shot Injuries Among U.S. Military Personnel
In the National Defense Authorization Act (NDAA) for fiscal year 2024, the U.S. Congress is requiring the U.S. Department of Defense (DoD) to study and report on poor health conditions that active duty members of the Armed Forces developed after administration of COVID-19 shots.1 The NDAA was passed in late 2023 and calls for “a […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]